On-Demand: The Next Generation of Packaging and Labeling

This innovative method increases flexibility, saves money, and supports the Critical Path Initiative.

With the increasing number of patient-specific and genetically based medications being developed and the globalization of clinical trials, pharmaceutical and biotechnology companies are facing greater pressures to increase efficiencies in clinical trial material (CTM) management. In particular, there is growing demand on clinical supplies teams to minimize CTM repackaging or overage, shorten packaging and labeling timelines, have the flexibility to customize supplies, and reduce the overall costs associated with CTM management. Oftentimes, these demands are implicit even in situations where significant last-minute protocol changes that affect CTM have been made—including changes in number of patients, sites, locations, duration of treatment, and dose regimen.

View Full Article

Author(s): 
Brian Moe .
Journal: 
Applied Clinical Trials, Aug 1, 2005 .